A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
